UP

Cancer immunotherapy drug 'less toxic and prolongs life'

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto
Cancer immunotherapy drug 'less toxic and prolongs life'

An immunotherapy drug that could save some cancer patients from the ordeal of extreme chemotherapy may also help them live longer, researchers say.

Axar.az reports citing BBC.

In a trial, pembrolizumab kept head and neck cancers at bay for an average of two years - five times longer than under chemotherapy.

The patients also suffered far fewer side-effects.

Cases of head and neck cancers are rising in the UK and most are diagnosed late, when they are hard to treat.

Date
2019.11.23 / 21:56
Author
Axar.az
See also

WHO says low risk of Nipah virus spreading beyond India

Asian countries step up airport checks over Nipah virus

Deadly Nipah virus cases reported in India

Robots get human-like “Smart Skin”

WHO warns of rapid spread of "Hong Kong Flu"

Japanese frog bacteria kill cancer cells

Stem cell drug offers non-opioid osteoarthritis pain relief

US develops AI tool for early breast cancer detection

Red meat increases stroke risk in older adults

Avoid alcohol in autumn to protect your immunity

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla